SCHEMBL14967792

SCHEMBL14967792

CC1CCCCCOC(=O)c2cc(cc(S(=O)(=O)O)c2)C(=O)O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.38
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
ESR2 Q92731 3/20 0.36
ALDH1A1 P00352 3/20 0.36
HSP90AA1 P07900 2/20 0.36
HSP90AB1 P08238 2/20 0.36
CYP3A4 P08684 2/20 0.36
NR1I2 O75469 1/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
OPRD1 P41143 1/20 0.32
ACVRL1 P37023 3/20 0.32
F13A1 P00488 1/20 0.31
TGM2 P21980 1/20 0.31
PGR P06401 2/20 0.31
BMPR1B O00238 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7784537 0.84 ING2 (0.37) SMN1; SMN2ALDH1A1PGR
SCHEMBL28880053 0.83 ALDH1A1 (0.32) ALDH1A1KMT2A
SCHEMBL30298635 0.81 ING2 (0.37) SMN1; SMN2ALDH1A1PGR
SCHEMBL5370947 0.81 ALDH1A1 (0.35) LMNAALDH1A1MEN1KMT2APGR
SCHEMBL9725438 0.80 LMNA (0.36) ESR1LMNASMN1; SMN2ESR2ALDH1A1
SCHEMBL4608729 0.78 LMNA (0.35) ESR1LMNASMN1; SMN2ESR2ALDH1A1
SCHEMBL11643499 0.78 ING2 (0.39) LMNASMN1; SMN2ALDH1A1
SCHEMBL7909485 0.78 ING2 (0.39) LMNASMN1; SMN2ALDH1A1
SCHEMBL29028819 0.71 TSHR (0.48) SMN1; SMN2ALDH1A1TP53MEN1KMT2A
SCHEMBL5069254 0.69 TSHR (0.50) SMN1; SMN2ALDH1A1TP53POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240324588-A1 ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS Genesee Valley Innovations, LLC 2024-10-03 US disclosed
EP-3578370-B1 AQUEOUS INK COMPOSITION COMPRISING POLYISOPRENE, PROCESS AND PRINTING PROCESS XEROX CORP (US) 2024-07-10 EP disclosed
EP-3578371-B1 WATERBORNE CLEAR INK COMPOSITIONS, PROCESS AND PRINTING PROCESS XEROX CORP (US) 2024-07-10 EP disclosed
EP-3578614-B1 SULFONATED POLYESTER INK XEROX CORP (US) 2023-12-13 EP disclosed
EP-3633459-B1 SURFACE ADDITIVE INFRARED TAGGANT TONER XEROX CORP (US) 2023-11-08 EP disclosed
CN-110564205-B Aqueous ink composition comprising polyisoprene 施乐公司 2022-11-25 CN disclosed
US-11281119-B1 Toner surface additive XEROX CORPORATION (US) 2022-03-22 US disclosed
EP-2780421-A1 DYE-ENCAPSULATED DISPERSIONS SUITABLE FOR PRINTING APPLICATIONS Dow Global Technologies LLC (US) 2014-09-24 EP disclosed
WO-2013074495-A1 DYE-ENCAPSULATED DISPERSIONS SUITABLE FOR PRINTING APPLICATIONS DOW GLOBAL TECHNOLOGIES LLC (US) 2013-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240324588-A1 ESSENTIAL OIL MICROPARTICLES FOR POWDER COATING APPLICATIONS EXOSC9, EXOSC4, PHOSPHO1 ESR1 454/4885LMNA 1182/4885SMN1; SMN2 2381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.